News

Barbie's first doll with Type 1 diabetes, which is available now for $10.99 each, includes a glucose monitor and insulin pump ...
Despite the federal government’s recent implementation of zero import duty on pharmaceuticals and active pharmaceutical ...
This March 1, 2023, photo shows a vial of Eli Lilly's Humalog insulin in New York. (AP Photo/Pablo Salinas) LOS ANGELES (CN) — A Superior Court judge, on Tuesday, told lawyers for the state of ...
New stem cell therapy offers hope for type 1 diabetes, freeing patients from insulin. Learn why diverse clinical trial ...
The analyst sees MannKind Corporation’s (NASDAQ:MNKD) inhaled insulin product as a considerably undervalued opportunity in ...
Barbie introduces a doll with type 1 diabetes, featuring a CGM and insulin pump, in collaboration with Breakthrough T1D. This ...
Barbie has taken a bold and heartfelt step toward inclusivity with the debut of a new doll representing children with type 1 ...
MariTide, a groundbreaking weight loss medication, shows 16% weight reduction in trials. Learn about this promising monthly ...
(THE CONVERSATION) Hurricanes, tornadoes and other extreme weather do not distinguish between urban and rural boundaries. But when a disaster strikes, there are big differences in how well people are ...
The One Big Beautiful Bill Act provides more opportunities for enrollees to fall through the cracks by adding red tape, ...
Investing.com -- Tandem Diabetes Care (NASDAQ: TNDM) stock fell 5% Wednesday morning after Citi downgraded the medical device maker to Sell from Neutral, citing intensifying competitive pressures.
The One Big Beautiful Bill Act provides more opportunities for enrollees to fall through the cracks by adding red tape, health experts say.